These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 19657486)

  • 41. [Are there still indications for albumin?].
    Mayr A; Mutz N; Hasibeder W
    Wien Klin Wochenschr; 1999 Jun; 111(11):449-50; author reply 451-3. PubMed ID: 10420500
    [No Abstract]   [Full Text] [Related]  

  • 42. Safety and efficacy of albumin administration in trauma.
    Chalidis B; Kanakaris N; Giannoudis PV
    Expert Opin Drug Saf; 2007 Jul; 6(4):407-15. PubMed ID: 17688384
    [TBL] [Abstract][Full Text] [Related]  

  • 43. High-dose intravenous immune globulin for stiff-person syndrome.
    Solaro C
    N Engl J Med; 2002 May; 346(22):1747-8; author reply 1747-8. PubMed ID: 12041528
    [No Abstract]   [Full Text] [Related]  

  • 44. High-dose intravenous immune globulin for stiff-person syndrome.
    Sudo K; Tajima Y; Matsumoto A
    N Engl J Med; 2002 May; 346(22):1747-8; author reply 1747-8. PubMed ID: 12037158
    [No Abstract]   [Full Text] [Related]  

  • 45. Intravenous immune globulin in neuromuscular disorders.
    Gupta S
    West J Med; 1997 Nov; 167(5):349-50. PubMed ID: 9392991
    [No Abstract]   [Full Text] [Related]  

  • 46. Safety of intravenous immunoglobulin treatment.
    Caress JB; Kennedy BL; Eickman KD
    Expert Opin Drug Saf; 2010 Nov; 9(6):971-9. PubMed ID: 20408737
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intravenous immunoglobulin induced meningoencephalitis.
    Nooraine J; Iyer RB; Raghavendra S
    Neurol India; 2014; 62(1):98-9. PubMed ID: 24608480
    [No Abstract]   [Full Text] [Related]  

  • 48. VI nerve palsy after intravenous immunoglobulin in Kawasaki disease.
    Rodríguez-Lozano A; Juárez-Echenique JC; Rivas-Larrauri F; Gámez-González LB; Yamazaki-Nakashimada M
    Allergol Immunopathol (Madr); 2014; 42(1):82-3. PubMed ID: 23340202
    [No Abstract]   [Full Text] [Related]  

  • 49. [Effects of plasma albumin infusion on minimal change nephrotic syndrome].
    Yoshimura A; Ideura T; Hashimoto Y; Koshikawa S
    Nihon Naika Gakkai Zasshi; 1988 Aug; 77(8):1219-23. PubMed ID: 3241104
    [No Abstract]   [Full Text] [Related]  

  • 50. [Are there still indications for albumin?].
    Steurer J
    Wien Klin Wochenschr; 1999 Jun; 111(11):450-1; author reply 451-3. PubMed ID: 10420501
    [No Abstract]   [Full Text] [Related]  

  • 51. Administration of intravenous immunoglobulin to a patient with hypogammaglobulinemia and anti-IgA antibodies.
    Lieberman P; Rachid R
    J Allergy Clin Immunol Pract; 2013; 1(6):704. PubMed ID: 24565726
    [No Abstract]   [Full Text] [Related]  

  • 52. Intravenous immunoglobulin infusion causing pseudohyponatremia.
    Ng SK
    Lupus; 1999; 8(6):488-90. PubMed ID: 10483022
    [No Abstract]   [Full Text] [Related]  

  • 53. Acute Onset of Anemia After IV Immunoglobulin.
    Gradidge E; Rodwig F; Warrier R
    Clin Pediatr (Phila); 2016 Jun; 55(6):572-3. PubMed ID: 26611894
    [No Abstract]   [Full Text] [Related]  

  • 54. Immunoglobulins: Benefits and risks from the patient's point of view.
    Revol B; Bickert L; Sarrot-Reynauld F; Allenet B
    Therapie; 2017 Dec; 72(6):683-684. PubMed ID: 28941580
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hepatitis associated with high dose intravenous gammaglobulin.
    Craig TJ; Davis W
    Ann Allergy; 1993 Sep; 71(3):276. PubMed ID: 8373001
    [No Abstract]   [Full Text] [Related]  

  • 56. [Administration of intravenous immunoglobulins in neurology. An evidence-based consensus: update 2010].
    Stangel M; Gold R
    Nervenarzt; 2011 Apr; 82(4):415-6, 418, 420 passim. PubMed ID: 20577707
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pseudohyponatraemia and hyperviscosity due to IVIG therapy in a term newborn.
    Tarcan A; Gökmen Z; Dikmenoğlu N; Gürakan B
    Acta Paediatr; 2005 Apr; 94(4):509-10. PubMed ID: 16092471
    [No Abstract]   [Full Text] [Related]  

  • 58. Pompholyx after intravenous immunoglobulin therapy for treatment of Guillain-Barré syndrome.
    Rhee DY; Park GH; Chang SE; Lee MW; Choi JH; Moon KC; Koh JK
    J Eur Acad Dermatol Venereol; 2009 May; 23(5):602-4. PubMed ID: 18761548
    [No Abstract]   [Full Text] [Related]  

  • 59. Is albumin administration harmful in critically ill patients? The patient's nitrogen and energy balance may provide an answer.
    Stehle G; Wunder A; Heene DL
    Crit Care Med; 2000 May; 28(5):1697. PubMed ID: 10834763
    [No Abstract]   [Full Text] [Related]  

  • 60. [Gammaglobulins].
    Chevrant-Breton J; Feyel-Dobrokhotov AC
    Ann Dermatol Venereol; 2007 Dec; 134(12):961-7. PubMed ID: 18166918
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.